Search clinical trials for: CN-sourced ipilimumab
Total 1178 results
-
Medical University of ViennaWithdrawn
-
Bristol-Myers SquibbActive, not recruitingRenal Cell CarcinomaFrance, Spain, Chile, United States, Argentina, Austria, Czechia, Greece, Italy, Mexico, Poland, Portugal, Romania, Russian Federation
-
Parker Institute for Cancer ImmunotherapyBristol-Myers SquibbCompleted
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedCarcinoma, Renal Cell | Clear-cell Metastatic Renal Cell CarcinomaSpain, France, Italy, Germany, United Kingdom, Belgium, Czechia, Austria
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada
-
Indus Hospital and Health NetworkUnknownForced Air Warming Effect on HypothermiaPakistan
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBladder Cancer | Urothelial CarcinomaNetherlands
-
Xencor, Inc.ICON plcActive, not recruitingRenal Cell Carcinoma | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Advanced Solid Tumors | Non-small Cell Lung Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Cervical Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma and other conditionsUnited States
-
Institut Claudius RegaudTerminated
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
University of Alabama at BirminghamRecruitingInfant, Newborn, Diseases | Infant, Premature, Diseases | Respiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia | Meconium Aspiration Syndrome | Transient Tachypnea of the NewbornUnited States
-
Winston ManimtimRecruitingInfant, Premature, Diseases | Respiratory Distress Syndrome | Bronchopulmonary DysplasiaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMelanomaArgentina, United States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Duke UniversityCompletedHigh Risk MelanomaUnited States
-
National Institute of Allergy and Infectious Diseases...Johns Hopkins Bloomberg School of Public HealthCompletedVirus Diseases | InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedVirus Diseases | InfluenzaUnited States
-
University of ZurichRecruitingMelanoma Stage IV | Leptomeningeal Metastasis | Non-small Cell Lung Cancer Stage IVSwitzerland
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
University of MinnesotaWithdrawn
-
Universita di VeronaNot yet recruitingHIV | HBV | Long COVID | NSCLC Stage IV | HCVItaly
-
Yale UniversityBristol-Myers SquibbActive, not recruitingSmall Cell Lung CancerUnited States
-
Gritstone bio, Inc.Bristol-Myers SquibbCompletedColorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer | Solid Tumor | Shared Neoantigen-Positive Solid TumorsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Boston Image Reading CenterActive, not recruiting
-
Universitair Ziekenhuis BrusselNot yet recruiting
-
Shanghai Henlius BiotechCompleted
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
Centre Leon BerardRecruiting
-
Persephone BiosciencesPharm-Olam InternationalRecruitingCarcinoma, Non-Small-Cell Lung | Carcinoma, ColorectalUnited States
-
Regeneron PharmaceuticalsSanofiTerminatedAdvanced Non-Small Cell Lung CarcinomaUnited States, Belgium, France, Germany, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedMalignant Pleural MesotheliomaNetherlands
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingSarcoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Lung Cancer | Pancreas Cancer | Liver Cancer | Ovary CancerChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbActive, not recruitingMesotheliomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingVarious Advanced CancerUnited States, Japan, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Czechia, Denmark, France, Hong Kong, Italy, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Singapore, Spain, ... and more
-
Sheba Medical CenterTerminatedA Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of ResponseIsrael
-
University of PittsburghBristol-Myers SquibbWithdrawnMelanomaUnited States
-
Lithuanian University of Health SciencesCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHealthy SubjectsSingapore
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingNeoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)Renal Cell CarcinomaUnited Kingdom, Netherlands
-
The Hong Kong Polytechnic UniversityTung Wah College; MindvividNot yet recruitingFrailty | Body Composition | Cognitive Function | Nutrition | Cognitive Frailty | Protective Diet Adherence
-
Boston Image Reading CenterRecruitingDry Macular DegenerationUnited States, Australia
-
Marmara UniversityCompletedGeneralized Aggressive Periodontitis
-
Brigham and Women's HospitalCompleted
-
University of Texas Southwestern Medical CenterCompletedKidney Cancer | Kidney Cancer Metastatic | Kidney Cancer, Stage IVUnited States
-
Vanderbilt UniversityWithdrawnCesarean SectionUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIUnited States, Netherlands, Australia
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States